Celldex Therapeutics, Inc. (CLDX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1237888,
    "name": "Celldex Therapeutics, Inc.",
    "stock_name": "Celldex Therapeutics, Inc.",
    "full_name": "Celldex Therapeutics, Inc.",
    "name_url": "stocks-analysis/celldex-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "29.60",
    "chg": 2.93,
    "chgp": "10.99%",
    "dir": 1,
    "prev_price": "26.67",
    "mcapval": "1,553.91",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US15117B2025",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.48 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/celldex-therapeutics-inc-1237888-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Celldex Therapeutics Hits Day High with 9.61% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-hits-day-high-with-961-surge-in-stock-price-3712568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelldexTherapeu_priceRelatedfactors_3712568.png",
        "date": "2025-11-18 17:26:05",
        "description": "Celldex Therapeutics, Inc. has seen a significant increase in its stock price today, contrasting with a slight decline in the S&P 500. While the company has shown a weekly gain, its longer-term performance reveals challenges, including negative cash flow and underperformance against the broader market."
      },
      {
        "title": "Celldex Therapeutics Hits Day High with Strong 7.72% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-hits-day-high-with-strong-772-intraday-surge-3707978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelldexTherapeu_priceRelatedfactors_3707978.png",
        "date": "2025-11-17 17:05:28",
        "description": "Celldex Therapeutics, Inc. experienced a significant stock price increase today, reaching an intraday high. Despite this uptick, the company has faced challenges, including a substantial decline in net sales and negative operating cash flow. Overall, its performance metrics indicate mixed results amid ongoing sector volatility."
      },
      {
        "title": "Celldex Therapeutics Stock Soars 7.5%, Hits Intraday High of $24.77",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-stock-soars-75-hits-intraday-high-of-2477-3693022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelldexTherapeu_priceRelatedfactors_3693022.png",
        "date": "2025-11-12 16:34:26",
        "description": "Celldex Therapeutics, Inc. experienced a notable increase in stock price on November 11, 2025, contrasting with the S&P 500's modest gain. However, the company has struggled with a significant decline in net sales and negative operating cash flow, reflecting ongoing profitability challenges and underperformance over the past year."
      },
      {
        "title": "Celldex Therapeutics Hits Day Low of $24.40 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-hits-day-low-of-2440-amid-price-pressure-3671569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelldexTherapeu_priceRelatedfactors_3671569.png",
        "date": "2025-11-04 18:29:34",
        "description": "Celldex Therapeutics, Inc. has faced significant stock price declines, with a notable drop today. The company reported a substantial decrease in net sales and negative operating cash flow, alongside a low debtors turnover ratio and negative return on equity, indicating ongoing financial challenges amid broader market gains."
      },
      {
        "title": "Celldex Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-price-increase-3649030",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CelldexTherapeu_technicaldot_3649030.png",
        "date": "2025-10-27 15:48:25",
        "description": "Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.72. The company has experienced significant volatility over the past year. Technical indicators present a mixed outlook, while its performance has varied compared to the S&P 500 over different time frames."
      },
      {
        "title": "Celldex Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-price-increase-3640460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CelldexTherapeu_technicaldot_3640460.png",
        "date": "2025-10-20 15:25:11",
        "description": "Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.83. The company has shown significant volatility over the past year, with a 52-week high of $29.38 and a low of $14.40, reflecting mixed performance indicators and varying returns compared to the S&P 500."
      },
      {
        "title": "Celldex Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celldex-therapeutics-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-performance-3601281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CelldexTherapeu_technicaldot_3601281.png",
        "date": "2025-10-07 20:40:38",
        "description": "Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.38. The company has experienced significant volatility over the past year, with a 52-week high of $31.66 and a low of $14.40, reflecting varied performance compared to the S&P 500."
      },
      {
        "title": "Is Celldex Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-celldex-therapeutics-inc-technically-bullish-or-bearish-3599192",
        "imagepath": "",
        "date": "2025-10-07 12:20:51",
        "description": "As of 3 October 2025, the technical trend for Celldex Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the monthly RSI indicates a bullish stance, supporting the overall positive outlook. Daily moving averages are also bullish, while the weekly KST is bullish, although the monthly KST is bearish. The Bollinger Bands show a mildly bullish trend weekly but are mildly bearish monthly, indicating some mixed signals. Dow Theory reflects a mildly bullish stance in both weekly and monthly assessments.\n\nIn terms of performance, the stock has returned 15.35% over the past month compared to the S&P 500's 4.15%, but it has underperformed over the longer term, with a 1-year return of -13.93% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish with moderate strength...."
      },
      {
        "title": "Is Celldex Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-celldex-therapeutics-inc-technically-bullish-or-bearish-3593922",
        "imagepath": "",
        "date": "2025-10-06 12:10:51",
        "description": "As of 3 October 2025, the technical trend for Celldex Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the monthly RSI is also bullish, indicating positive momentum. The daily moving averages are bullish, supporting the overall bullish stance. However, the monthly Bollinger Bands are mildly bearish, and the KST shows a bearish signal on the monthly timeframe, which introduces some caution. The Dow Theory indicates a mildly bullish trend on both weekly and monthly timeframes.\n\nIn terms of performance, Celldex has outperformed the S&P 500 over the past month with a return of 11.86% compared to the S&P 500's 4.15%, but it has underperformed over the longer-term periods, particularly the 1Y and 3Y returns. Overall, the current technical stance is bullish, with moderate strength driven by positive signals in MACD and RSI, despite some mixed indicators in Bollinger Ba..."
      }
    ],
    "total": 17,
    "sid": "1237888",
    "stock_news_url": "https://www.marketsmojo.com/news/celldex-therapeutics-inc-1237888"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Celldex Therapeutics Hits Day High with 9.61% Surge in Stock Price

2025-11-18 17:26:05

Celldex Therapeutics, Inc. has seen a significant increase in its stock price today, contrasting with a slight decline in the S&P 500. While the company has shown a weekly gain, its longer-term performance reveals challenges, including negative cash flow and underperformance against the broader market.

Celldex Therapeutics Hits Day High with Strong 7.72% Intraday Surge

2025-11-17 17:05:28

Celldex Therapeutics, Inc. experienced a significant stock price increase today, reaching an intraday high. Despite this uptick, the company has faced challenges, including a substantial decline in net sales and negative operating cash flow. Overall, its performance metrics indicate mixed results amid ongoing sector volatility.

Celldex Therapeutics Stock Soars 7.5%, Hits Intraday High of $24.77

2025-11-12 16:34:26

Celldex Therapeutics, Inc. experienced a notable increase in stock price on November 11, 2025, contrasting with the S&P 500's modest gain. However, the company has struggled with a significant decline in net sales and negative operating cash flow, reflecting ongoing profitability challenges and underperformance over the past year.

Celldex Therapeutics Hits Day Low of $24.40 Amid Price Pressure

2025-11-04 18:29:34

Celldex Therapeutics, Inc. has faced significant stock price declines, with a notable drop today. The company reported a substantial decrease in net sales and negative operating cash flow, alongside a low debtors turnover ratio and negative return on equity, indicating ongoing financial challenges amid broader market gains.

Celldex Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators

2025-10-27 15:48:25

Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.72. The company has experienced significant volatility over the past year. Technical indicators present a mixed outlook, while its performance has varied compared to the S&P 500 over different time frames.

Celldex Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-20 15:25:11

Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.83. The company has shown significant volatility over the past year, with a 52-week high of $29.38 and a low of $14.40, reflecting mixed performance indicators and varying returns compared to the S&P 500.

Celldex Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations

2025-10-07 20:40:38

Celldex Therapeutics, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $26.38. The company has experienced significant volatility over the past year, with a 52-week high of $31.66 and a low of $14.40, reflecting varied performance compared to the S&P 500.

Is Celldex Therapeutics, Inc. technically bullish or bearish?

2025-10-07 12:20:51

As of 3 October 2025, the technical trend for Celldex Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the monthly RSI indicates a bullish stance, supporting the overall positive outlook. Daily moving averages are also bullish, while the weekly KST is bullish, although the monthly KST is bearish. The Bollinger Bands show a mildly bullish trend weekly but are mildly bearish monthly, indicating some mixed signals. Dow Theory reflects a mildly bullish stance in both weekly and monthly assessments. In terms of performance, the stock has returned 15.35% over the past month compared to the S&P 500's 4.15%, but it has underperformed over the longer term, with a 1-year return of -13.93% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish with moderate strength....

Is Celldex Therapeutics, Inc. technically bullish or bearish?

2025-10-06 12:10:51

As of 3 October 2025, the technical trend for Celldex Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the monthly RSI is also bullish, indicating positive momentum. The daily moving averages are bullish, supporting the overall bullish stance. However, the monthly Bollinger Bands are mildly bearish, and the KST shows a bearish signal on the monthly timeframe, which introduces some caution. The Dow Theory indicates a mildly bullish trend on both weekly and monthly timeframes. In terms of performance, Celldex has outperformed the S&P 500 over the past month with a return of 11.86% compared to the S&P 500's 4.15%, but it has underperformed over the longer-term periods, particularly the 1Y and 3Y returns. Overall, the current technical stance is bullish, with moderate strength driven by positive signals in MACD and RSI, despite some mixed indicators in Bollinger Ba...

View All News